Evidence map›Paper›PMID 14757742›Full record

ArticleThe Journal of experimental medicine2004

WIP regulates signaling via the high affinity receptor for immunoglobulin E in mast cells.

Alexander Kettner, Lalit Kumar, Inés M Antón, Yoji Sasahara, Miguel de la Fuente, Vadim I Pivniouk, Hervé Falet, John H Hartwig, Raif S Geha

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Stem cell factor programs the mast cell activation phenotype.Journal of immunology (Baltimore, Md. : 1950) · 2012
    Article
  8. Review
  9. Cytoskeleton in mast cell signaling.Frontiers in immunology · 2012
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. WIP is essential for lytic granule polarization and NK cell cytotoxicity.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  18. Article
  19. WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP).Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  20. Decoding IgE Fc receptors.Immunologic research · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Alexander KettnerDivision of Immunology, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Lalit Kumar
Inés M Antón
Yoji Sasahara
Miguel de la Fuente
Vadim I Pivniouk
Hervé Falet
John H Hartwig
Raif S Geha
Children's Hospital · TNBrigham and Women's Hospital · USUniversity of Turin · IT

Funding

WIP in TCR signaling and actin reorganizationP01HL059561 · NHLBI · IMMUNE DISEASE INSTITUTE, INC. · PI GEHA, RAIF SALIM · 1997 to 2012
$21.8M
TRANSGENIC MODELS OF T CELL RECEPTOR IMMUNODEFICIENCIESP01AI035714 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TERHORST, CORNELIS P · 1994 to 2007
$9.3M
NHLBI NIH HHS P01 HL059561NIAID NIH HHS AI-35714NIAID NIH HHS P01 AI035714
6 · The paper itself

Abstract

Wiskott-Aldrich syndrome protein-interacting protein (WIP) stabilizes actin filaments and is important for immunoreceptor-mediated signal transduction leading to actin cytoskeleton rearrangement in T and B cells. Here we report a role for WIP in signaling pathways downstream of the high affinity receptor for immunoglobulin (Ig)E (FcepsilonRI) in mast cells. WIP-deficient bone marrow-derived mast cells (BMMCs) were impaired in their capacity to degranulate and secrete interleukin 6 after FcepsilonRI ligation. Calcium mobilization, phosphorylation of Syk, phospholipase C-g2, and c-Jun NH2-terminal kinase were markedly decreased in WIP-deficient BMMCs. WIP was found to associate with Syk after FcepsilonRI ligation and to inhibit Syk degradation as evidenced by markedly diminished Syk levels in WIP-deficient BMMCs. WIP-deficient BMMCs exhibited no apparent defect in their subcortical actin network and were normal in their ability to form protrusions when exposed to an IgE-coated surface. However, the kinetics of actin changes and the cell shape changes that follow FcepsilonRI signaling were altered in WIP-deficient BMMCs. These results suggest that WIP regulates FcepsilonRI-mediated mast cell activation by regulating Syk levels and actin cytoskeleton rearrangement.

Indexed as

ActinsAnimalsB-LymphocytesBone Marrow CellsCarrier ProteinsCytoskeletal ProteinsGene DeletionHistamine ReleaseHumansIntracellular Signaling Peptides and ProteinsMast CellsMiceMice, KnockoutReceptors, IgET-LymphocytesWiskott-Aldrich SyndromeActinsCarrier ProteinsCytoskeletal ProteinsIntracellular Signaling Peptides and ProteinsReceptors, IgEWaspip protein, mouseWIPF1 protein, human

Identifiers

PMID14757742
PMCPMC2211794
OpenAlexW2153469919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.